Gonzalo Castillo-Rojas
Gonzalo Castillo-Rojas has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yolanda López-Vidal
Laboratorio del Programa de Inmunología Molecular Microbiana. Depto. de Microbiología y Parasitología, Facultad de Medicina, UNAM. Circuito Interior, Ciudad Universitaria, Coyoacán, Ciudad de México C.P. 04510, México
4 shared publications - Alejandro Schcolnik-Cabrera
Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada
1 shared publication Andrés Mejía Estrada
Programa de Inmunología Molecular Microbiana, Facultad de Medicina
1 shared publication- Armando Gamboa-Domínguez
Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico
1 shared publication Brenda G. Barrios-Plata
Programa de Inmunología Molecular Microbiana, Facultad de Medicina
1 shared publication- Claudia Ivette Rivas-Ortiz
Programa de Inmunología Molecular Microbiana, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 04510, Mexico
1 shared publication
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1)
Integrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum
- 1 November 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1)
Open AccessIntegrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum
- Open Access
- 1 September 2026
- Published by IWA Publishing in Water Science & Technology
- Vol. 94 (5) , 575-587
Tracking resistance: antimicrobial susceptibility of bacteria in domestic water from the Mezquital Valley, Mexico
Graphical abstract illustrating the dynamics of wastewater that is used in the Mezquital Valley. The diagram shows the water types analyzed through bacterial determination and susceptibility tests, highlighting the presence of extended-spectrum beta-lactamase-producing E. coli. Antibiotic-resistant bacteria (ARB) in water sources constitute an important public health challenge; consequently, monitoring is necessary to mitigate their dissemination. We describe the resistance profile of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in two zones from the Mezquital Valley, Hidalgo, where wastewater is reused for irrigation. Three sampling campaigns were conducted between 2016 and 2017 in this area. Household water and irrigation samples were processed through membrane filtration and cultured on antibiotic-supplemented media (n = 105). Presumptive E. coli colonies were isolated, after which we performed susceptibility profiles and identification using the MicroScan system. The presence of E. coli was confirmed in 96.6% of isolates, and 82.4% of them were ESBL producers. Household water from Zone A showed higher ESBL-E. coli counts compared with Zone B (p = 0.0247), likely due to its proximity to wastewater canals. Similar profiles between household water and wastewater isolates were observed (p = 0.81). Multidrug resistance (MDR) was detected in domestic and wastewater isolates. No resistance was determined for groundwater. Household water with the presence of ARB suggests wastewater contact with water supplied for human use. This case reinforces the need to meet standards and use risk assessments to mitigate negative effects of wastewater on the environment, human populations, and animals.
- 1 September 2026
- Published by IWA Publishing in Water Science & Technology
- Vol. 94 (5) , 575-587
Open AccessTracking resistance: antimicrobial susceptibility of bacteria in domestic water from the Mezquital Valley, Mexico
Graphical abstract illustrating the dynamics of wastewater that is used in the Mezquital Valley. The diagram shows the water types analyzed through bacterial determination and susceptibility tests, highlighting the presence of extended-spectrum beta-lactamase-producing E. coli. Antibiotic-resistant bacteria (ARB) in water sources constitute an important public health challenge; consequently, monitoring is necessary to mitigate their dissemination. We describe the resistance profile of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in two zones from the Mezquital Valley, Hidalgo, where wastewater is reused for irrigation. Three sampling campaigns were conducted between 2016 and 2017 in this area. Household water and irrigation samples were processed through membrane filtration and cultured on antibiotic-supplemented media (n = 105). Presumptive E. coli colonies were isolated, after which we performed susceptibility profiles and identification using the MicroScan system. The presence of E. coli was confirmed in 96.6% of isolates, and 82.4% of them were ESBL producers. Household water from Zone A showed higher ESBL-E. coli counts compared with Zone B (p = 0.0247), likely due to its proximity to wastewater canals. Similar profiles between household water and wastewater isolates were observed (p = 0.81). Multidrug resistance (MDR) was detected in domestic and wastewater isolates. No resistance was determined for groundwater. Household water with the presence of ARB suggests wastewater contact with water supplied for human use. This case reinforces the need to meet standards and use risk assessments to mitigate negative effects of wastewater on the environment, human populations, and animals.
- Open Access
- 17 July 2024
- Published by MDPI AG in Preprints.org
Stable Trend of Antimicrobial Susceptibility Profiles of Helicobacter pylori Isolated from Patients during a 12-Year Period in Mexico
An efficacious treatment of H. pylori infection is cornerstone for the global control of the diseases caused by this bacterium. Continuous epidemiologic surveillance of susceptibility of H. pylori to the antibiotics recommended for its eradication is highly recommended. This study aimed to determine the antimicrobial susceptibility pattern of 651 isolates from five different collections isolated between 1996 to 2008 in México City. The susceptibility profile of H. pylori isolates was determined by the E-test strips for each antibiotic (amoxicillin, clarithromycin, metronidazole, and tetracycline). Antimicrobial susceptibility testing showed a very high proportion of H pylori strains susceptible to amoxicillin, clarithromycin, and tetracycline (94.5%, 95%, and 99.5 %, respectively). In contrast, a high proportion (95%) of isolates was resistant to metronidazole. Notably, the proportion of susceptible/resistant strains to the 4 antibiotics over 5 consecutive time periods remained stable over time. Despite a wide use of amoxicillin and clarithromycin in the general population, the H pylori high susceptibility to these 2 antibiotics has been preserved during more than a decade. The high prevalence of resistance to metronidazole in H. pylori strains in our population compromises its use in the empirical treatment of H. pylori infection.
- 17 July 2024
- Published by MDPI AG in Preprints.org
Open AccessStable Trend of Antimicrobial Susceptibility Profiles of Helicobacter pylori Isolated from Patients during a 12-Year Period in Mexico
An efficacious treatment of H. pylori infection is cornerstone for the global control of the diseases caused by this bacterium. Continuous epidemiologic surveillance of susceptibility of H. pylori to the antibiotics recommended for its eradication is highly recommended. This study aimed to determine the antimicrobial susceptibility pattern of 651 isolates from five different collections isolated between 1996 to 2008 in México City. The susceptibility profile of H. pylori isolates was determined by the E-test strips for each antibiotic (amoxicillin, clarithromycin, metronidazole, and tetracycline). Antimicrobial susceptibility testing showed a very high proportion of H pylori strains susceptible to amoxicillin, clarithromycin, and tetracycline (94.5%, 95%, and 99.5 %, respectively). In contrast, a high proportion (95%) of isolates was resistant to metronidazole. Notably, the proportion of susceptible/resistant strains to the 4 antibiotics over 5 consecutive time periods remained stable over time. Despite a wide use of amoxicillin and clarithromycin in the general population, the H pylori high susceptibility to these 2 antibiotics has been preserved during more than a decade. The high prevalence of resistance to metronidazole in H. pylori strains in our population compromises its use in the empirical treatment of H. pylori infection.
- Open Access
Overview of Gene Expression Analysis in Gastric Disease Infected with Helicobacter pylori: CLDN1 and MMP9 Could Be Biomarkers for Early Diagnosis of Gastric Cancer
Chronic Helicobacter pylori infection produces several lesions in the human stomach, which can progress to chronic atrophic gastritis and gastric cancer. To date, there is very little information on gene expression in chronic atrophic gastritis and its relationship with progression to gastric cancer. In this study, we performed a gene expression analysis during chronic atrophic gastritis in order to identify possible biomarkers that allow an early diagnosis of gastric cancer. We studied biopsies from patients with chronic atrophic gastritis and gastric cancer. The biopsies were analyzed by a gene expression microarray and corroborated by qPCR and validated through immunohistochemistry. Our results revealed that gene expression profiles in patients with chronic atrophic gastritis showed molecular changes of the gastric mucosa, leading to gastric cancer. The gene expression profiles of CLDN1, CLDN7, OLFM4, C-MYC and MMP9 were more notable from the chronic atrophic gastritis. The gene expression patterns observed in this study allowed the identification of CLDN1 and MMP9 proteins as promising biomarkers of early stages of gastric cancer development.
Open AccessOverview of Gene Expression Analysis in Gastric Disease Infected with Helicobacter pylori: CLDN1 and MMP9 Could Be Biomarkers for Early Diagnosis of Gastric Cancer
Chronic Helicobacter pylori infection produces several lesions in the human stomach, which can progress to chronic atrophic gastritis and gastric cancer. To date, there is very little information on gene expression in chronic atrophic gastritis and its relationship with progression to gastric cancer. In this study, we performed a gene expression analysis during chronic atrophic gastritis in order to identify possible biomarkers that allow an early diagnosis of gastric cancer. We studied biopsies from patients with chronic atrophic gastritis and gastric cancer. The biopsies were analyzed by a gene expression microarray and corroborated by qPCR and validated through immunohistochemistry. Our results revealed that gene expression profiles in patients with chronic atrophic gastritis showed molecular changes of the gastric mucosa, leading to gastric cancer. The gene expression profiles of CLDN1, CLDN7, OLFM4, C-MYC and MMP9 were more notable from the chronic atrophic gastritis. The gene expression patterns observed in this study allowed the identification of CLDN1 and MMP9 proteins as promising biomarkers of early stages of gastric cancer development.